USPTO serial 87802210
VAYA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CALLOWAY, CHRISTINA DENISE
- Law office
- TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with VAYA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Kfar Baruch, IL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline Zion
JACQUELINE ZION PEARL COHEN ZEDEK LATZER BARATZ LLP1500 BROADWAY, 12TH FLNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary supplements; medical foods for dietary management of diseases and conditions; pharmaceuticals, namely, pharmaceutical preparations for the treatment or prevention of Attention Deficit Disorder (ADD)/Attention Deficit Hyperactivity Disorder (ADHD), dyslexia, learning disorders, stress, anxiety, Sleep, epilepsy, concentration and attention impairment and mood deterioration; pharmaceutical preparations for the treatment and prevention of diseases and conditions associated with lipid metabolism, hyperlipidemia and hypertriglyceridemia as reducing serum levels of both cholesterol and triglycerides, and for the treatment and prevention of cardiovascular disease (CVD) and coronary heart disease (CHD) as reducing oxidation levels of serum low density lipoproteins (LDL) and macrophage, and by reducing inflammation and hypertension; pharmaceuticals, namely, pharmaceutical preparations for the treatment or prevention of age-associated memory impairment, mild cognitive impairment, pre-Alzheimer's disease, Alzheimer's disease, predementia syndrome, dementia, subjective cognitive decline, early memory impairment, and age related cognitive decline | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 6, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 6, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 25, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 7, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 7, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 7, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 28, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 28, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 25, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2018 | NWAP | NEW APPLICATION ENTERED | — |